Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 60, Issue 9, Pages 3828-3850Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.7b00017
Keywords
-
Categories
Funding
- Industrial Macromolecular Crystallography Association
- Hauptman-Woodward Medical Research Institute
- DOE Office of Science [DE-AC02-06CH11357]
Ask authors/readers for more resources
Members of the BET family of bromodomain containing proteins have been identified as potential targets for blocking proliferation in a variety of cancer cell lines. A two-dimensional NMR fragment screen for binders to the bromodomains of BRD4 identified a phenylpyridazinone fragment with a weak binding affinity (1, K-i = 160 mu M). SAR investigation of fragment 1, aided by X-ray structure-based design, enabled the synthesis of potent pyridone and macrocyclic pyridone inhibitors exhibiting single digit nanomolar potency in both biochemical and cell based assays. Advanced analogs in these series exhibited high oral exposures in rodent PK studies and demonstrated significant tumor growth inhibition efficacy in mouse flank xenograft models
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available